NIAID has funded discovery and development of the delta inulin adjuvant for many years.

Monday, June 3, 2024 Researchers Identify How Delta Inulin Vaccine Adjuvant Works Hand injects vaccine through a syringe into a person's shoulder muscle. Credit: NIAID After decades of mystery, scientists have uncovered how the NIAID-supported delta inulin vaccine adjuvant works, lowering the hurdle to regulatory approval for vaccine candidates that contain it. Adjuvants are substances formulated as part of a vaccine to boost immune responses and enhance vaccine effectiveness. NIAID has funded the discovery and development of the delta inulin adjuvant for many years, currently through a tuberculosis vaccine adjuvant research program. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period.  This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107